Drug intelligence / Profile preview

Dermaglós

Development stage
Unknown
Lead developer
Andromaco
Modality
Small Molecules
Administration
Topical
01

Overview

Dermaglós is a prominent brand of dermatological and skin-care products developed by Laboratorios Andrómaco, primarily marketed in Argentina and other Latin American regions. The flagship therapeutic formulation is an over-the-counter (OTC) topical cream or emulsion containing a combination of Vitamin A (retinol), Vitamin E (tocopherol), and Allantoin. It is indicated for the promotion of skin healing, the prevention and treatment of stretch marks (striae distensae), the management of minor burns and solar erythema, and the hydration of dry or irritated skin. Vitamin A facilitates skin regeneration by modulating gene expression through retinoic acid receptors, while Vitamin E provides antioxidant defense against free radicals, and Allantoin acts as a soothing agent that enhances the skin's moisture-binding capacity. The Dermaglós portfolio has expanded to include specialized lines for sun protection, facial aesthetics, and pediatric care.

Brand names
Dermaglós
02

Targets

RARA (Retinoic acid receptor alpha)RARG (Retinoic acid receptor gamma)RARB (Retinoic acid receptor beta)

Beyond the preview

Go deeper on Dermaglós.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermaglós.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call